Sorevar 200 mg filmom obložene tablete
| Name | Sorevar 200 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-694514311 |
| Active Substance | sorafenibtosilat |
| Composition | jedna filmom obložena tableta sadrži 200 mg sorafeniba (u obliku sorafenibtosilata) |
| Pharmaceutical Form | Filmom obložena tableta |
| Manufacturer | Genepharm S.A., Pallini, Attiki, Grčka
Pharmacare Premium Ltd., Birzebbugia, Malta |
| Marketing Authorisation Holder | Galenika International Kft., Baross utca 165/3, Budaörs, Mađarska |
| Marketing Authorisation Date | 08.07.2025 |
| MA Period of Validity | 08.07.2030 |
| Classification Number | UP/I-530-09/23-01/86 |
| Registration Number | 381-12-01/171-25-10 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01EX02 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
